-+ 0.00%
-+ 0.00%
-+ 0.00%

Actuate Therapeutics Announces Phase 2 Elraglusib Data for Metastatic Pancreatic Cancer Selected for ASCO GI 2026 Presentation

Reuters·12/18/2025 13:45:27

Please log in to view news